Compounds > 2-tert-butylhydroquinone
Page last updated: 2024-08-21

2-tert-butylhydroquinone and Diabetes, Gestational

2-tert-butylhydroquinone has been researched along with Diabetes, Gestational in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, J; Liu, H; Shang, L1
Rong, X; Song, H; Wang, Y; Wei, N; Xu, Y; Yang, X1

Other Studies

2 other study(ies) available for 2-tert-butylhydroquinone and Diabetes, Gestational

ArticleYear
Tert-butylhydroquinone Mitigates Renal Dysfunction in Pregnant Diabetic Rats
    Endocrine, metabolic & immune disorders drug targets, 2023, Volume: 23, Issue:5

    Topics: Animals; Antioxidants; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female; Fetal Weight; Humans; Kidney; Kidney Diseases; Lipids; Metformin; Oxidative Stress; Pregnancy; Rats; Streptozocin; Tumor Necrosis Factor-alpha

2023
Tertiary butylhydroquinone alleviates gestational diabetes mellitus in C57BL/KsJ-Lep db/+ mice by suppression of oxidative stress.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:9

    Topics: Animals; Antioxidants; Blood Glucose; Diabetes, Gestational; Disease Models, Animal; Female; Hydroquinones; Leptin; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Pregnancy; Reactive Oxygen Species; Up-Regulation

2019